Combined therapy of SGLT2i and GLP1ra reduces all-cause mortality in patients with type 2 diabetes with a higher impact on women

Back

ESC2025 Premium Access

Combined therapy of SGLT2i and GLP1ra reduces all-cause mortality in patients with type 2 diabetes with a higher impact on women

Session: Cardiorenal-metabolic triad: the global health challenge

Topic: Cardiovascular Disease in Women

Speaker: Doctor D. Garcia Vega (Ourense, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor David Garcia Vega

Ourense University Hospital Complex, Ourense (Spain)

0 follower

4 more presentations in this session

State-of-the-art lecture on inflammation and cardiovascular disease

Speaker: Professor J. Deanfield (London, GB)

Access

Slides

Video

Associations between C-reactive protein levels and mortality in individuals with atherosclerotic cardiovascular disease and chronic kidney disease: results from the UK Discover database

Speaker: Professor K. Ray (London, GB)

Cumulative adiposity burden and cardiovascular risk trajectories: validating the 2025 clinical obesity criteria

Speaker: Doctor J. Yang (Shanghai, CN)

Sex differences in cardio-kidney metabolic syndrome: insights from the FINE-HEART pooled analysis of >18,000 trial participants

Speaker: Doctor M. Pabon (Boston, US)

Access the full session

Cardiorenal-metabolic triad: the global health challenge

Speakers: Doctor D. Garcia Vega, Professor J. Deanfield, Professor K. Ray, Doctor J. Yang, Doctor M. Pabon

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources